Cell-Intrinsic Barriers of T Cell-Based Immunotherapy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Trends in Molecular Medicine

• Publication date

  2016-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molmed.2016.10.002PMID 27825667PMCID PMC5135632
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

  2016cited by this paper
• Abstract B32: Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses

  2016cited by this paper
• Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.

  2016cited by this paper
• Learning from PD-1 Resistance: New Combination Strategies.

  2016cited by this paper
• Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.

  2016cited by this paper
• Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

  2016influential reference
• Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection

  2016cited by this paper
• Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

  2016cited by this paper
• Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion.

  2016cited by this paper
• Generating long‐lived CD8+ T‐cell memory: Insights from epigenetic programs

  2016cited by this paper
• Combining Epigenetic and Immunotherapy to Combat Cancer.

  2016cited by this paper
• Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion

  2016cited by this paper
• T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections.

  2016cited by this paper
• The future of cancer treatment: immunomodulation, CARs and combination immunotherapy

  2016cited by this paper
• MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2

  2016cited by this paper
• Epigenetic silencing of Th1 type chemokines shapes tumor immunity and immunotherapy

  2015cited by this paper
• Adoptive cellular therapy: A race to the finish line

  2015cited by this paper
• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

  2015cited by this paper
• Adoptive cell transfer as personalized immunotherapy for human cancer

  2015cited by this paper
• 4-1BB Costimulation Ameliorates T Cell Exhaustion Induced by Tonic Signaling of Chimeric Antigen Receptors

  2015cited by this paper
• Engineering CAR-T cells: Design concepts.

  2015cited by this paper
• Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells.

  2015cited by this paper
• Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.

  2015cited by this paper
• Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway.

  2015cited by this paper
• Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.

  2015influential reference
• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

  2015cited by this paper
• Lineage relationship of CD8+ T cell subsets is revealed by progressive changes in the epigenetic landscape

  2015cited by this paper
• Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.

  2015cited by this paper
• T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.

  2015cited by this paper
• Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

  2015cited by this paper
• Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma.

  2015cited by this paper
• Regulation of DNA methylation dictates Cd4 gene expression during development of helper and cytotoxic T cell lineages

  2015cited by this paper
• Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.

  2015cited by this paper
• Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model

  2015cited by this paper
• Exploiting the curative potential of adoptive T‐cell therapy for cancer

  2014cited by this paper
• Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.

  2014cited by this paper
• Epigenetic manipulation restores functions of defective CD8⁺ T cells from chronic viral infection.

  2014cited by this paper
• Chimeric antigen receptor T cells for sustained remissions in leukemia.

  2014cited by this paper
• Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15.

  2014cited by this paper
• Epigenetic Manipulation Restores Functions of Defective CD8+ T Cells From Chronic Viral Infection.

  2014cited by this paper
• Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

  2014cited by this paper
• Mechanisms of epigenetic memory.

  2014cited by this paper
• Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation.

  2014cited by this paper
• Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function

  2013cited by this paper
• T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion

  2013cited by this paper
• Dynamic regulation of transcriptional states by chromatin and transcription factors

  2013cited by this paper
• Cutting Edge: Prolonged Exposure to HIV Reinforces a Poised Epigenetic Program for PD-1 Expression in Virus-Specific CD8 T Cells

  2013cited by this paper
• Innate and adaptive immune cells in the tumor microenvironment

  2013cited by this paper
• Transcriptional control of effector and memory CD8+ T cell differentiation

  2012cited by this paper
• How do CARs work?

  2012cited by this paper
• Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection

  2012influential reference
• Progressive Loss of Memory T Cell Potential and Commitment to Exhaustion during Chronic Viral Infection

  2012cited by this paper
• Adoptive immunotherapy for cancer: harnessing the T cell response

  2012cited by this paper
• The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer

  2012cited by this paper
• Functions of DNA methylation: islands, start sites, gene bodies and beyond

  2012cited by this paper
• Cutting Edge: Persistently Open Chromatin at Effector Gene Loci in Resting Memory CD8+ T Cells Independent of Transcriptional Status

  2011cited by this paper
• T cell exhaustion

  2011cited by this paper
• Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

  2011cited by this paper
• The role of retinoic acid in tolerance and immunity.

  2011cited by this paper
• Differentiation-dependent functional and epigenetic landscapes for cytokine genes in virus-specific CD8+ T cells

  2011cited by this paper
• Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

  2011cited by this paper
• Immune microenvironments in solid tumors: new targets for therapy.

  2011cited by this paper
• PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

  2010cited by this paper
• Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection

  2010cited by this paper
• Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

  2010cited by this paper
• Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

  2009cited by this paper
• A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy.

  2009cited by this paper
• Histone Acetylation Facilitates Rapid and Robust Memory CD8 T Cell Response through Differential Expression of Effector Molecules (Eomesodermin and Its Targets: Perforin and Granzyme B)1

  2008cited by this paper
• Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade

  2008cited by this paper
• Stability and flexibility of epigenetic gene regulation in mammalian development

  2007cited by this paper
• Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

  2007cited by this paper
• Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells.

  2006cited by this paper
• Naïve and Memory CD4+ T Cell Survival Controlled by Clonal Abundance

  2006cited by this paper
• Rapid Demethylation of the IFN-γ Gene Occurs in Memory but Not Naive CD8 T Cells1

  2006cited by this paper
• Restoring function in exhausted CD8 T cells during chronic viral infection

  2006cited by this paper
• Persistence of Multiple Tumor-Specific T-Cell Clones Is Associated with Complete Tumor Regression in a Melanoma Patient Receiving Adoptive Cell Transfer Therapy

  2005cited by this paper
• Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment

  2003cited by this paper
• Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1

  2003cited by this paper
• Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus

  2000cited by this paper
• A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon

  2000cited by this paper
• The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery.

  1999cited by this paper
• Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

  1999cited by this paper
• Induction and Exhaustion of Lymphocytic Choriomeningitis Virus–specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I–Peptide Complexes

  1998cited by this paper
• Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function

  1998cited by this paper
• Enhancement of Antitumor Immunity by CTLA-4 Blockade

  1996cited by this paper
• Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

  1993cited by this paper
• Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

  1993cited by this paper
• Microenvironment and Immunology Immune Inhibitory Molecules Lag-3 and Pd-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

  year unknowncited by this paper

• Genetic and Epigenetic Indicators Predicting Response to Immune Checkpoint Inhibitors

  2025cites this paper
• Cascade amplification of therapeutic payloads for cancer immunotherapy

  2025cites this paper
• Aging and immunity: the age-old tango

  2025cites this paper
• Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors

  2024cites this paper
• Chronic viral infection alters PD-1 locus subnuclear localization in cytotoxic CD8+ T cells

  2024cites this paper
• 5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer

  2024cites this paper
• Assessment of CTLA-4 Gene Expression Levels on CD8+ T Cells in Renal Transplant Patients and Relation with Serum sCTLA-4 Levels

  2024cites this paper
• Recent advances in targeted drug delivery for the treatment of glioblastoma.

  2024cites this paper
• Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosis

  2024cites this paper
• New opportunities to overcome T cell dysfunction: the role of transcription factors and how to target them.

  2024cites this paper
• Host-cell Interactions of Engineered T cell Micropharmacies

  2023cites this paper
• Genetic alterations shape innate immune cells to foster immunosuppression and cancer immunotherapy resistance

  2023cites this paper
• Immune Diseases Associated with Aging: Molecular Mechanisms and Treatment Strategies

  2023cites this paper
• A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response

  2023cites this paper
• Host Interactions with Engineered T-cell Micropharmacies

  2023cites this paper
• Nonredundant Upregulation of CD112R (PVRIG) and PD-1 on Cytotoxic T Lymphocytes Located in T Cell Nests of Colorectal Cancer.

  2023cites this paper
• HDAC7 controls anti-viral and anti-tumor immunity by CD8+ T cells

  2022cites this paper
• Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer

  2022cites this paper
• Role of CXCR5+ CD8+ T cells in human immunodeficiency virus-1 infection

  2022cites this paper
• Cancer-cell-intrinsic mechanisms shaping the immunosuppressive landscape of prostate cancer

  2022cites this paper
• Clinical application of cell‐based therapies opportunities and challenges

  2022cites this paper
• Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy

  2022cites this paper
• Droplet microfluidics for functional temporal analysis and cell recovery on demand using microvalves: application in immunotherapies for cancer.

  2022cites this paper
• Exosomal microRNAs shuttling between tumor cells and macrophages: cellular interactions and novel therapeutic strategies

  2022cites this paper
• LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation

  2022cites this paper
• Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma

  2022cites this paper
• New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy

  2022cites this paper
• Epigenetic programming of the immune responses in cancer

  2022cites this paper
• T-cell Exhaustion in Organ Transplantation

  2021cites this paper
• Magnitude of Off-Target Allo-HLA Reactivity by Third-Party Donor-Derived Virus-Specific T Cells Is Dictated by HLA-Restriction

  2021cites this paper
• Lysosome activable polymeric vorinostat encapsulating PD-L1KD for a combination of HDACi and immunotherapy

  2021cites this paper
• The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment

  2021cites this paper
• Immune Aging and Immunotherapy in Cancer

  2021cites this paper
• Enhancing adoptive CD8 T cell therapy by systemic delivery of tumor associated antigens

  2021cites this paper
• The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

  2020cites this paper
• Clinical implication of serologic indexes and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

  2020cites this paper
• CAR T cell therapy: newer approaches to counter resistance and cost

  2020cites this paper
• The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas

  2020cites this paper
• Tumoral PD-1hiCD8+ T cells are partially exhausted and predict favorable outcome in triple-negative breast cancer.

  2020cites this paper
• CAR T and CAR NK cells in multiple myeloma: Expanding the targets.

  2020cites this paper
• Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response

  2020cites this paper
• Cancer Immunology: A Translational Medicine Context

  2020cites this paper
• Rewriting History: Epigenetic Reprogramming of CD8+ T Cell Differentiation to Enhance Immunotherapy.

  2020cites this paper
• Single cell multiomic analysis of T cell exhaustion in vitro

  2019cites this paper
• Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells.

  2019cites this paper
• Human iPSC Generation from Antigen-Specific T Cells.

  2019cites this paper
• Overexpression of PDE4A Acts as Checkpoint Inhibitor Against cAMP-Mediated Immunosuppression in vitro

  2019cites this paper
• Multiple Myeloma, Targeting B-Cell Maturation Antigen With Chimeric Antigen Receptor T-Cells

  2019cites this paper
• Integrative network modeling reveals mechanisms underlying T cell exhaustion

  2019cites this paper
• Evolution of chimeric antigen receptor (CAR) T cell therapy: current status and future perspectives

  2019cites this paper
• Chimeric Antigen Receptor T Cell Immunotherapy for Tumor: A Review of Patent Literatures

  2019cites this paper
• Proteomics analysis reveals the interleukin-35-dependent regulatory mechanisms affecting CD8+ T-cell functions.

  2019cites this paper
• Harnessing tumor-associated macrophages as aids for cancer immunotherapy

  2019cites this paper
• PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma

  2019cites this paper
• Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma

  2019cites this paper
• Hitting the Target: How T Cells Detect and Eliminate Tumors

  2018cites this paper
• Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance

  2018cites this paper
• Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells

  2018cites this paper
• Evaluating the expression patterns of multiple inhibitory receptors associated with T-cell exhaustion using multicolor flow cytometry

  2018cites this paper
• CD8 + T-cell responses in vaccination: reconsidering targets and function in the context of chronic antigen stimulation

  2018cites this paper
• The function and dysfunction of memory CD8+ T cells in tumor immunity

  2018cites this paper
• Immunotherapy with Genetically Modified T Cells

  2018cites this paper
• De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation.

  2017cites this paper
• From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely

  2017cites this paper
• Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS

  2017cites this paper
• Can T cells be too exhausted to fight back?

  2016cites this paper